# New York Blood Center, Inc. – FDA Inspection, Jul 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/87f0a51b-259c-4191-b34f-f452b5c5bebe
Source feed: FDA_Inspections

> FDA inspection 1327194 of New York Blood Center, Inc., July 17, 2026. Classification: No Action Indicated (NAI). 3 citations under 21 CFR part 606. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1327194
- Company Name: New York Blood Center, Inc.
- Inspection Date: 2026-07-17
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New York District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1181149 - 2022-09-30
- FDA Inspection 1069250 - 2018-09-19
- FDA Inspection 960944 - 2016-02-26
- FDA Inspection 883474 - 2014-06-24
- FDA Inspection 748519 - 2011-10-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/ea0e2960-d3d1-4b67-b67b-d1824e9f6778

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d